Axon Enterprise, Inc. (NASDAQ:AXON) President Sells $829,377.13 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner sold 1,291 shares of the stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $642.43, for a total transaction of $829,377.13. Following the sale, the president now owns 181,892 shares in the company, valued at $116,852,877.56. This represents a 0.70 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Joshua Isner also recently made the following trade(s):

• On Tuesday, November 12th, Joshua Isner sold 20,000 shares of Axon Enterprise stock. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00.

Axon Enterprise Trading Down 2.1 %

Shares of Axon Enterprise stock traded down $13.54 during midday trading on Tuesday, reaching $635.76. The company had a trading volume of 1,496,467 shares, compared to its average volume of 581,323. The firm has a market cap of $48.48 billion, a PE ratio of 164.28, a P/E/G ratio of 14.19 and a beta of 1.01. The stock has a fifty day moving average price of $548.26 and a 200 day moving average price of $411.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a fifty-two week low of $241.72 and a fifty-two week high of $698.67.

Wall Street Analyst Weigh In

Several analysts recently weighed in on AXON shares. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Robert W. Baird increased their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. JMP Securities lifted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Finally, The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $488.67.

Institutional Investors Weigh In On Axon Enterprise

Several large investors have recently modified their holdings of the company. Quent Capital LLC lifted its stake in Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC increased its stake in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after acquiring an additional 79 shares during the period. Brooklyn Investment Group bought a new position in Axon Enterprise during the third quarter worth $41,000. Finally, Planning Capital Management Corp grew its holdings in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.